Sign inGet started
Get started

Clinical Trials

Studies and Trials

Holistic Approach to Improve Quality of Life

Study published in the Journal of Precision Oncology

View case study

Key Highlights

Clinical trial chart

Domain

Baseline

After 6 wks

Improvement

Onco-nutrition

~5.5

~8.7

↑58% (p<0.05)

Movement & meditation

~5.9

~6.9

↑17% (p<0.05)

Mental well-being

~6.2

~7.5

↑21% (p<0.05)

  • In a prospective pilot of 25 head-and-neck cancer patients over 6 weeks, the CARER-45 holistic intervention (nutrition + movement/meditation + mental well-being) showed statistically significant improvements across all domains measured.

  • 100% patient compliance — high acceptability and engagement with the CARER model.

Clinical Trial Study in Collaboration with Eris Lifesciences

Industry partnership agreement executed with Eris Lifesciences Ltd.

We are presently conducting a multi-center real-world evidence (RWE) study and interventional clinical trial in the domain of head and neck cancers, in collaboration with one of India's leading pharmaceutical partners (Eris).

Trial status: patient recruitment ongoing (Q2 2024–Q4 2025); interim analysis expected 2025.

Documentation: Industry partnership agreement executed with Eris Lifesciences Ltd.

Key Highlights

  • Trial Type: Observational, real-world data collection

  • Focus Area: Head and neck cancers

  • Participating Sites: 8 of the most reputed cancer institutions in India, including:

    • Tata Memorial Hospital

    • Rajiv Gandhi Cancer Institute

    • Narayana Health

Holistic Approach to Improve Quality of Life

Study Title: A Clinical Study on the Impact of Integrative Oncology on Quality of Life and Treatment Outcomes in Haematologic Cancer Patients at AIIMS (Delhi)

We are conducting a clinical trial in collaboration with the All-India Institute of Medical Sciences (AIIMS), one of India's premier academic medical centers, to evaluate the impact of integrative oncology on treatment outcomes and quality of life in patients with hematologic malignancies.

The study is being implemented jointly with CanSupport, a leading non-profit organization providing palliative and psycho-social support services to cancer patients.

Key Highlights

  • Design: 3-month pilot (n = 60) — to expand into RCT

  • Interventions: personalised nutrition, movement/meditation, and mental wellbeing

  • Assessment Tools: QLQ-C30 (QoL), MMAS-8 (adherence), AE reporting, CSAT

  • Collaborators: AIIMS Dept. of Haematology Oncology + CanSupport

  • Status: protocol approved, onboarding initiated (2025)

  • Ethics: approvals underway per AIIMS IRB guidelines